Matthew L Freedman
- Dana-Farber Cancer Institute (no department on record)
From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.
FY2026 NIH rank #4,752
- Program Leader
- R01 Holder
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 6362098Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Internal Medicine
NIH Funding · FY2026
Linked Award Amount
$3.6M
Full award amounts, FY2026
Award Records
4
Records listing this PI
Award-Linked Rank
#4,752
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2026 award records by amount
NIH award records listing Matthew L Freedman as a PI. Multi-PI records show the full award amount for context.
- $2.5Maward amount
- 5R01CA259058-04R01Co-investigatorCommon biology underlying pleiotropic breast, prostate and ovarian cancer risk lociUT Health Science Center Houston · Internal Medicine (NIH department code)$590Kaward amount
- 5R01CA300092-02R01Contact PIMapping the epigenetic dynamics of prostate cancer progression: integrating liquid biopsies and single-cell epigenomics for early detection of lineage plasticity and clinical decision-making$406.5Kaward amount
- 3R01CA300092-02S1R01Contact PIMapping the epigenetic dynamics of prostate cancer progression: integrating liquid biopsies and single-cell epigenomics for early detection of lineage plasticity and clinical decision-making$201.5Kaward amount
Award organizations
Organizations that administered FY2026 awards listing Matthew L Freedman as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardDana-Farber Cancer Institute
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #4834
- 2024Entered Top 25% NationallyRanked #4834
- 2025Multi-Institutional ResearchAwards at 2 institutions
- 2025R01 Grant Holder
- 2025Program/Center Grant Leader
- 2026$5M Cumulative Funding
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Matthew L Freedman.
Mark M. Pomerantz
Dana-Farber Cancer Institute
6
shared awards
Andre Bergman
Dana-Farber Cancer Institute
3
shared awards
Eliezer M Van Allen
Dana-Farber Cancer Institute
3
shared awards
Himisha Beltran
Dana-Farber Cancer Institute
3
shared awards
Steven P. Balk
Dana-Farber Cancer Institute
3
shared awards
Svitlana Tyekucheva
Dana-Farber Cancer Institute
3
shared awards
Wilbert Zwart
Dana-Farber Cancer Institute
3
shared awards
Alexander Gimelbrant
Dana-Farber Cancer Institute
2
shared awards
Alexander Gusev
Dana-Farber Cancer Institute
2
shared awards
Bogdan Pasaniuc
Dana-Farber Cancer Institute
2
shared awards